Skip to main content

Part of the book series: Ernst Schering Research Foundation Workshop ((SCHERING FOUND,volume 46))

  • 91 Accesses

Abstract

Estrogens represent the key ovarian hormone produced by the developing preovulatory follicle. Serum concentrations start to rise from the midfollicular phase onwards, coinciding with the visualization of the dominant follicle upon ultrasound. Estrogens are synthesized by aromatase activity of the granulosa cells and secreted into the follicular fluid compartment, where 1,000-fold higher levels can be observed. Its significance for oocyte maturation and fertilizing potential remains unknown.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 229.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adashi EY (1986) Clomiphene citrate-initiated ovulation: A clinical update. Sem Reprod Endocrinol 4:255–275

    Article  Google Scholar 

  • Boostanfar R, Jain JK, Mishell DR, Paulson RJ (2001) A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction. Fertil Steril 75:1024–1026

    Article  PubMed  CAS  Google Scholar 

  • Goldstein SR, Siddhanti S, Ciaccia AV, Plouffe L (2000) A pharmacological review of selective oestrogen receptor modulators. Hum Reprod Upd 6:212–224

    Article  CAS  Google Scholar 

  • Greenblatt RB, Barfield WE, Jungek EC, Ray AW (1961) Induction of ovulation with MRL/41. Am J Obstet Gynecol 178:127–130

    Google Scholar 

  • Hughes E, Collins J, Vandekerckhove P (2002) Clomiphene citrate for ovulation induction in women with oligo-amenorrhea (Cochrane review). The Cochrane Review Library, Issue 4, Oxford

    Google Scholar 

  • Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC (1999) Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation. J Clin Endocrinol Metab 84:1617–1622

    Article  PubMed  CAS  Google Scholar 

  • Imani B, Eijkemans MJ, de Jong FH, Payne NN, Bouchard P, Giudice LC, Fauser BC (2000) Free androgen index and leptin are the most prominent endocrine predictors of ovarian response during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 85:676–682

    Article  PubMed  CAS  Google Scholar 

  • Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC (2002) A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Fertil Steril 77:91–97

    Article  PubMed  Google Scholar 

  • Jordan VC (1997) The origin of antiestrogens. In: Dempster DW, Jordan CG (eds) Estrogens and antiestrogens. Lippincott-Raven Publishers, Philadelphia, pp 9–20

    Google Scholar 

  • Kistner RW, Smith OW (1961) Observations on the use of a nonsteroidal estrogen antagonist: MER-25. Fertil Steril 12:121–141

    PubMed  CAS  Google Scholar 

  • Laven JS, Imani B, Eijkemans MJ, Fauser BC (2002) New approaches to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 57:755–767

    Article  PubMed  Google Scholar 

  • Mitwally MF, Casper RF (2001) Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 75:305–309

    Article  PubMed  CAS  Google Scholar 

  • Riggs B, Hartmann LC (2003) Selective estrogen-receptor modulators — mechanisms of action and application to clinical practice. N Engl J Med 348:618–629

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

K. S. Korach A. Hillisch K. H. Fritzemeier

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Fauser, B.C.J.M., Laven, J.S.E. (2004). Role of Estrogens in Ovarian Dysfunction and Fertility. Options for New Therapies with SERMs. In: Korach, K.S., Hillisch, A., Fritzemeier, K.H. (eds) New Molecular Mechanisms of Estrogen Action and Their Impact on Future Perspectives in Estrogen Therapy. Ernst Schering Research Foundation Workshop, vol 46. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05386-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-05386-7_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-05388-1

  • Online ISBN: 978-3-662-05386-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics